Dark Forest Capital Management LP Adverum Biotechnologies, Inc. Transaction History

Dark Forest Capital Management LP

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 13, 2022	SELL	$1.23 - $1.95 $2,926 - $4,639	-2,379 Closed	0 $0
Q4 2021 Feb 11, 2022	SELL	$1.74 - $2.4 $10,215 - $14,090	-5,871 Reduced 71.16%	2,379 $4,000
Q3 2021 Nov 12, 2021	BUY	$2.08 - $3.6 $17,160 - $29,700	8,250 New	8,250 $18,000

524K

Ticker ADVM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 99,333,600
Market Cap $720M
Description
Adverum Biotechnologies, Inc., a clinical-stage gene therapy company, develops gene therapy product candidates to treat ocular and rare diseases. Its lead product candidate is ADVM-022, a single intravitreal injection gene therapy candidate used for the treatment of patients with chronic retinal, including wet age-related macular degeneration an...

Get notified when there are updates to the investment portfolio of Dark Forest Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Dark Forest Capital Management LP with notifications on news.